Hero Technologies (OTCMKTS:HENC) versus USANA Health Sciences (NYSE:USNA) Head-To-Head Analysis

USANA Health Sciences (NYSE:USNAGet Rating) and Hero Technologies (OTCMKTS:HENCGet Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, analyst recommendations, earnings, institutional ownership and dividends.

Institutional and Insider Ownership

52.6% of USANA Health Sciences shares are owned by institutional investors. 0.4% of USANA Health Sciences shares are owned by insiders. Comparatively, 0.2% of Hero Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

USANA Health Sciences has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Hero Technologies has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500.

Earnings and Valuation

This table compares USANA Health Sciences and Hero Technologies’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
USANA Health Sciences $998.60 million 1.23 $69.35 million $3.59 17.71
Hero Technologies N/A N/A -$3.42 million N/A N/A

USANA Health Sciences has higher revenue and earnings than Hero Technologies.

Profitability

This table compares USANA Health Sciences and Hero Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
USANA Health Sciences 6.94% 16.92% 12.15%
Hero Technologies N/A N/A -457.02%

Analyst Ratings

This is a summary of recent ratings and recommmendations for USANA Health Sciences and Hero Technologies, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences 1 1 0 0 1.50
Hero Technologies 0 0 0 0 N/A

USANA Health Sciences currently has a consensus price target of $52.75, suggesting a potential downside of 17.03%. Given USANA Health Sciences’ higher probable upside, research analysts clearly believe USANA Health Sciences is more favorable than Hero Technologies.

Summary

USANA Health Sciences beats Hero Technologies on 9 of the 9 factors compared between the two stocks.

About USANA Health Sciences

(Get Rating)

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm’s brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

About Hero Technologies

(Get Rating)

Hero Technologies, Inc. engages in the exploration, production, and development of oil and gas properties. It focuses on Australia’s Cooper Basin, which is located in State of South Australia. The company was founded on May 14, 2004 and is headquartered in Dover, DE.

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.